Group One Trading
AMRI

Group One Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Group One Trading’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,700
Closed -$59K – 5502
2017
Q2 		$59K Buy
2,700
+2,600
+2,600% +$47.2K ﹤0.01% 3427
2017
Q1 		$1K Buy
+100
New +$1.64K ﹤0.01% 4553
2013
Q3 		– Sell
-1,600
Closed -$19K – 5867
2013
Q2 		$19K Buy
+1,600
New +$17.3K ﹤0.01% 4118

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Group One Trading's AMRI Position: Q3 2017 in Review

Group One Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 18,203 shares — an estimated $395K sold.

Group One Trading first reported a position in AMRI in Q2 2013 and held it in 10 quarters. The position peaked at $660K in Q2 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Group One Trading reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 18,203 Albany Molecular Research Inc shares in Q3 2017, an estimated $395K.
  • Group One Trading first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Albany Molecular Research Inc position peaked at $660K in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.